Nucleic Acid and Peptide Aptamers: Fundamentals and Bioanalytical Aspects
- 30 December 2011
- journal article
- review article
- Published by Wiley in Angewandte Chemie
- Vol. 51 (6), 1316-1332
- https://doi.org/10.1002/anie.201006630
Abstract
In recent years new nucleic acid and protein‐based combinatorial molecules have attracted the attention of researchers working in various areas of science, ranging from medicine to analytical chemistry. These molecules, called aptamers, have been proposed as alternatives to antibodies in many different applications. The aim of this Review is to illustrate the peculiarities of these combinatorial molecules which have initially been explored for their importance in molecular medicine, but have enormous potential in other biotechnological fields historically dominated by antibodies, such as bioassays. A description of these molecules is given, and the methods for their selection and production are also summarized. Moreover, critical aspects related to these molecules are discussed.Keywords
This publication has 180 references indexed in Scilit:
- Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugatesAdvanced Drug Delivery Reviews, 2010
- Nano Aptasensor for Protective Antigen Toxin of AnthraxAnalytical Chemistry, 2010
- Aptamer−Nanoparticle Strip Biosensor for Sensitive Detection of Cancer CellsAnalytical Chemistry, 2009
- Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology ApproachAccounts of Chemical Research, 2009
- Generation of Highly Specific Aptamers via Micromagnetic SelectionAnalytical Chemistry, 2009
- On the Signaling of Electrochemical Aptamer‐Based Sensors: Collision‐ and Folding‐Based MechanismsElectroanalysis, 2009
- High Specificity, Electrochemical Sandwich Assays Based on Single Aptamer Sequences and Suitable for the Direct Detection of Small-Molecule Targets in Blood and Other Complex MatricesJournal of the American Chemical Society, 2009
- Enrichment of Cancer Cells Using Aptamers Immobilized on a Microfluidic ChannelAnalytical Chemistry, 2008
- HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer TherapyChemMedChem, 2008
- Ligand-regulated Peptide Aptamers that Inhibit the 5′-AMP-activated Protein KinaseJournal of Molecular Biology, 2007